Back to search
Bone Metabolism
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Bone Metabolism trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Bone Metabolism trials you may qualify forX-linked hypophosphataemia (XLH) is a rare, hereditary condition. The genetic defect leads to low blood phosphate levels and vitamin D suppression. Phosphate is…
Background: Fanconi anemia (FA) is a rare, inherited cancer syndrome. FA causes a range of physical issues. Children with FA may have abnormal features; these…
The consumption of an adequate quantity of protein in the diet is essential to maintain a healthy body composition and functioning. It is also well established…
The goal of this observational study is to evaluate whether preoperative fat-free mass predicts post-operative weight loss in patients undergoing Roux-En-Y gast…
The goal of this observational study is to develop a registry of Brazilian patients with hereditary cardiovascular diseases, combining clinical and genomic data…
Osteoporosis is a multifactorial disease in which genetic predispositions play a key role in its development. A better understanding of family history and clini…
This study will investigate the effects on bone quality of a medication (Teriparatide) used to treat people with severe osteoporosis. Teriparatide is the only b…
Teriparatide (PTH) is the only bone formation therapy that has been approved for the treatment of postmenopausal osteoporosis in Canada. Osteoporosis is current…
Background: Clinical Genetics Branch (CGB) researchers study individuals and populations at high genetic risk of cancer in order to improve our understanding o…